Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized-controlled, Single-blind Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastases

NCT03831243 is registered in ClinicalTrials.gov with Cancer Research Antwerp as lead sponsor.

NCT NCT03831243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03831243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized-controlled, Single-blind Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastases
Lead sponsor
Cancer Research Antwerp
Phase
Not applicable
Overall status
Completed
Start date
April 9, 2019
Completion date
October 26, 2023
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastasis to bone, neoplasm metastasis, radiotherapy